Eurosurv. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020

[tetano]

SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020

• Alexandre Belot[SUP]1[/SUP], Denise Antona[SUP]2[/SUP], Sylvain Renolleau[SUP]3[/SUP], Etienne Javouhey[SUP]3[/SUP], V?ronique Hentgen[SUP]4[/SUP], Fran?ois Angoulvant[SUP]4[/SUP], Christophe Delacourt[SUP]5[/SUP], Xavier Iriart[SUP]6[/SUP], Caroline Ovaert[SUP]6[/SUP], Brigitte Bader-Meunier[SUP]7[/SUP], Isabelle Kone-Paut[SUP]7[/SUP], Daniel Levy-Bruhl[SUP]2[/SUP]

End of April 2020, French clinicians observed an increase in cases presenting with paediatric inflammatory multisystem syndrome (PIMS). Nationwide surveillance was set up and demonstrated temporospatial association with the coronavirus disease (COVID-19) epidemic for 156 reported cases as at 17 May: 108 were classified as confirmed (n = 79), probable (n = 16) or possible (n = 13) post-COVID-19 PIMS cases. A continuum of clinical features from Kawasaki-like disease to myocarditis was observed, requiring intensive care in 67% of cases.

full article

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.22.2001010#html_fulltext